Outcomes of Anti-BCMA CAR T Cell Therapy for Relapsed/refractory Multiple Myeloma: A Meta-Analysis

被引：0
|
作者：
Gagelmann, Nico [1 ]
Ayuk, Francis [1 ]
Atanackovic, Djordje [2 ]
Kroeger, Nicolaus [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Univ Utah, Salt Lake City, UT USA
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O122
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] OVERALL RESPONSE AND COMPLETE RESPONSE WITH ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) : A SYSTEMATIC REVIEW AND META-ANALYSIS
    Aggarwal, S.
    Bela, A.
    Topaloglu, O.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
  • [22] Updated Phase 1 Results of C-CAR088, an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
    Qu, Xiaoyan
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Huang, Jiaqi
    Li, Jing
    Zheng, Shirley
    Zhu, Kevin
    Lan, Liping
    Chen, Shiyi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Lu, Peihua
    Qiu, Lugui
    Li, Jianyong
    BLOOD, 2021, 138 : 1830 - +
  • [23] Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma
    Samur, Mehmet K.
    Fulciniti, Mariateresa
    Aktas-Samur, Anil
    Bazarbachi, Abdul Hamid
    Tai, Yu-Tzu
    Campbell, Timothy B.
    Petrocca, Fabio
    Hege, Kristen
    Kaiser, Shari
    Anderson, Kenneth
    Munshi, Nikhil C.
    BLOOD, 2020, 136
  • [24] Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy
    Qi, Yuekun
    Li, Hujun
    Qi, Kunming
    Zhu, Feng
    Cheng, Hai
    Chen, Wei
    Yan, Zhiling
    Li, Depeng
    Sang, Wei
    Fei, Xiaoming
    Gu, Weiying
    Miao, Yuqing
    Huang, Hongming
    Wang, Ying
    Qiu, Tingting
    Qiao, Jianlin
    Pan, Bin
    Shi, Ming
    Wang, Gang
    Li, Zhenyu
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2286 - 2295
  • [25] A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma
    Zhang, Huan
    Liu, Man
    Xiao, Xia
    Lv, Hairong
    Jiang, Yanyu
    Li, Xin
    Yuan, Ting
    Zhao, Mingfeng
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1418 - 1427
  • [26] Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis
    Akhtar, Othman Salim
    Sheeba, Ba Aqeel
    Azad, Farhan
    Alessi, Lauren
    Hansen, Doris
    Alsina, Melissa
    Baz, Rachid
    Shain, Kenneth
    Cruz, Ariel Grajales
    Puglianini, Omar Castaneda
    Liu, Hien
    Blue, Brandon
    Nishihori, Taiga
    Al Jumayli, Mohammed
    Extermann, Martine
    Locke, Frederick L.
    Mhaskar, Rahul
    Freeman, Ciara Louise
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
  • [27] Anti-BCMA CAR T-cell Therapy Reins in Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (07) : 817 - 819
  • [28] High Efficacy and Safety of Nanobody Based Anti-BCMA CAR-T Cell Therapy in Treating Patients with Relapsed or Refractory Multiple Myeloma
    Zhang, Xian
    Wang, Lin
    Yang, Junfang
    Li, Jingjing
    Liu, Hongxing
    Li, Jianqiang
    Lu, Peihua
    BLOOD, 2023, 142
  • [29] An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Qu, Xiaoyan
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Zheng, Chengxiao
    Yan, Xiuxiu
    Lv, Xiaoteng
    Lan, Liping
    Yang, Dingzhu
    Huo, Ningning
    Han, Ting
    Zhao, Dijun
    Qin, Shichao
    Wu, Junfeng
    Yao, Xin
    Zhu, Shigui
    Ren, Jiaqiang
    Zhang, Li
    Huang, Jiaqi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Li, Jianyong
    Lu, Peihua
    BLOOD, 2020, 136
  • [30] Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Qu, Xiaoyan
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Dan
    Huang, Jiaqi
    Zhu, Shigui
    Yao, Xin
    Li, Jing
    Zheng, Chengxiao
    Zhu, Kevin
    Wei, Yutian
    Lv, Xiaoteng
    Lan, Liping
    Yao, Yihong
    Zhou, Daobin
    Lu, Peihua
    Qiu, Lugui
    Li, Jianyong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
12345